Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine-Prilocaine Cream for Pain in First-Trimester Abortion
NCT03508804Phase 3Withdrawn
- Sponsor
- Stanford University
- Start
- Dec 2020
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of lidocaine 10% oropharyngeal spray and prilocaine in pain (2 arms), sponsored by Stanford University. Primary endpoint: Pain perceived as measured by a Visual Analog Scale. Planned start Dec 2020; status: withdrawn.
02
Drugs
lidocaine 10% oropharyngeal sprayprilocaine
03
Conditions
pain
Beyond the preview
Go deeper on NCT03508804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03508804.